Rubin, Evan – Trademark Portfolio

Entity Type: 01

Rubin, Evan holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 1 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include MITM and ·O·C·E·A·N· OSTEOPATHIC CENTER FOR EDUCATION AND NUTRITION. The owner is based in Tinton Falls, NJ.

55 N. Gilbert Street, #3102

Tinton Falls, NJ 07701

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Rubin, Evan's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Rubin, Evan have?

Rubin, Evan has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Rubin, Evan file in?

Rubin, Evan files trademarks across 2 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 44 (Medical Services). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.

What are Rubin, Evan's most well-known trademarks?

Rubin, Evan's registered trademark portfolio includes well-known marks such as MITM and ·O·C·E·A·N· OSTEOPATHIC CENTER FOR EDUCATION AND NUTRITION. These are among 2 currently registered trademarks in the portfolio.

What is Rubin, Evan's trademark registration success rate?

Rubin, Evan has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.